(Q37057317)

18 August 2017

1 reference

title

Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease (English)

1 reference

mild cognitive impairment

18 August 2017

0 references

1 reference

inferred from title

cognitive dysfunction

1 reference

Karl Herholz

1

1 reference

18 August 2017

1 March 2008

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

18 August 2017

1 reference

18 August 2017

35 Suppl 1

1 reference

18 August 2017

S25-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0699-4

18 August 2017

0 references

cites work

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-007-0699-4

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

12 December 2020

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

1 reference

12 December 2020

Acetylcholinesterase imaging: its use in therapy evaluation and drug design

1 reference

12 December 2020

Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection

1 reference

12 December 2020

Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling

1 reference

12 December 2020

Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease.

1 reference

12 December 2020

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease

1 reference

12 December 2020

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

1 reference

12 December 2020

Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease

1 reference

12 December 2020

PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor

1 reference

12 December 2020

In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).

1 reference

12 December 2020

In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjects.

1 reference

12 December 2020

Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system

1 reference

12 December 2020

In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.

1 reference

12 December 2020

The ratio of acetylcholinesterase to butyrylcholinesterase influences the specificity of assays for each enzyme in human brain

1 reference

12 December 2020

Changes in brain cholinesterases in senile dementia of Alzheimer type.

1 reference

12 December 2020

Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease

1 reference

12 December 2020

Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity

1 reference

12 December 2020

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.

1 reference

12 December 2020

Molecular interactions of acetylcholinesterase with senile plaques.

1 reference

12 December 2020

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

12 December 2020

Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET.

1 reference

12 December 2020

Cerebral acetylcholine esterase activity in mild cognitive impairment

1 reference

12 December 2020

Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain

1 reference

12 December 2020

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

1 reference

12 December 2020

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

1 reference

12 December 2020

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

1 reference

12 December 2020

In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog

1 reference

12 December 2020

PET measurement of cerebral acetylcholine esterase activity without blood sampling

1 reference

12 December 2020

Brain acetylcholinesterase activity in Alzheimer disease measured by positron emission tomography

1 reference

12 December 2020

Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution.

1 reference

12 December 2020

Evaluation of simplified kinetic analyses for measurement of brain acetylcholinesterase activity using N-[11C]Methylpiperidin-4-yl propionate and positron emission tomography

1 reference

12 December 2020

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

1 reference

12 December 2020

Pharmacological evaluation of [11C]donepezil as a tracer for visualization of acetylcholinesterase by PET.

1 reference

12 December 2020

The amygdala and Alzheimer's disease: positron emission tomographic study of the cholinergic system

1 reference

12 December 2020

In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease

1 reference

12 December 2020

Evaluation of the binding characteristics of [5-(11)C-methoxy]Donepezil in the rat brain for in vivo visualization of acetylcholinesterase

1 reference

12 December 2020

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

1 reference

12 December 2020

Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.

1 reference

12 December 2020

Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.

1 reference

12 December 2020

PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00259-007-0699-4

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18196237